Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGENUS INC Board/Management Information 2019

Aug 2, 2019

34023_rns_2019-08-02_9714ebb0-df81-4afd-b31a-28e5fab40286.zip

Board/Management Information

Open in viewer

Opens in your device viewer

8-K 1 d786023d8k.htm 8-K 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 30, 2019

AGENUS INC.

(Exact name of registrant as specified in its charter)

Delaware 000-29089 06-1562417
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

3 Forbes Road

Lexington, MA 02421

(Address of principal executive offices, including zip code)

(781) 674-4400

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered or to be registered pursuant to Section 12(b) of the Act.

Title of each class Trading symbol(s) Name of each exchange on which registered
Common stock, par value $0.01 AGEN The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On July 30, 2019, Christian Cortis, PhD, Chief Strategy Officer and Head of Finance of Agenus Inc. (“Agenus”), informed Agenus that he is stepping down from his role and resigning effective as of August 14, 2019. Christine M. Klaskin, Agenus’ Vice President, Finance and principal accounting officer, will retain her roles and re-assume the role of principal financial officer. Ms. Klaskin has served in various finance roles at Agenus since 1996. Additional biographical information about Ms. Klaskin is contained in Agenus’ prior filings with the Securities and Exchange Commission.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 2, 2019
By: /s/ Evan D. Kearns
Evan D. Kearns
VP, General Counsel and Secretary